Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Solé-Ribalta

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Anales De Pediatria|July 9, 2021
Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccineJohanna Martínez-Osorio, Juan José García-García, Fernando Moraga-Llop, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|November 2, 2020
Necrotizing pneumonia due to Streptococcus pneumoniae in children during the period of non-systematic use of PCV13 in Catalonia, SpainSebastià González-Peris, Magda Campins, Juan José García-García, et al.
Pediatric Pulmonology|February 21, 2019
Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine eraAlvaro Díaz-Conradi, Sergi Hernández, Juan José García-García, et al.
Plos One|August 15, 2017
Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control studyÁngela Domínguez, Pilar Ciruela, Sergi Hernández, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|December 6, 2021
Necrotizing pneumonia due to Streptococcus pneumoniae in children during the period of non-systematic use of PCV13 in Catalonia, SpainSebastià González-Peris, Magda Campins, Juan José García-García, et al.
Anales De Pediatria|October 1, 2020
[Characteristics of patients with invasive pneumococcal disease requiring admission to intensive care units]Alvaro Díaz-Conradi, Juan José García-García, Sebastià González Peris, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Anales De Pediatria|July 9, 2021
Invasive pneumococcal disease in children under 60 months before and after availability of 13-valent conjugate vaccineJohanna Martínez-Osorio, Juan José García-García, Fernando Moraga-Llop, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|November 2, 2020
Necrotizing pneumonia due to Streptococcus pneumoniae in children during the period of non-systematic use of PCV13 in Catalonia, SpainSebastià González-Peris, Magda Campins, Juan José García-García, et al.
Pediatric Pulmonology|February 21, 2019
Complicated pneumococcal pneumonia with pleural effusion or empyema in the 13-valent pneumococcal conjugate vaccine eraAlvaro Díaz-Conradi, Sergi Hernández, Juan José García-García, et al.
Plos One|August 15, 2017
Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control studyÁngela Domínguez, Pilar Ciruela, Sergi Hernández, et al.
Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.)|December 6, 2021
Necrotizing pneumonia due to Streptococcus pneumoniae in children during the period of non-systematic use of PCV13 in Catalonia, SpainSebastià González-Peris, Magda Campins, Juan José García-García, et al.
Anales De Pediatria|October 1, 2020
[Characteristics of patients with invasive pneumococcal disease requiring admission to intensive care units]Alvaro Díaz-Conradi, Juan José García-García, Sebastià González Peris, et al.
Pageof 2